Dermatological Reactions to Anti-Glaucoma Eye Drops
A review of dermatological adverse events associated with anti-glaucoma eye drop is provided.
Bullous Pemphigoid
Bullous Pemphigoid, Psoriasis Linked to Increased Risk for Alzheimer Disease
The relationships between Alzheimer disease and several different skin disorders is assessed.
Mortality in Bullous Pemphigoid and Pemphigus Vulgaris
Causes of death in patients with bullous pemphigoid (BP) and pemphigus vulgaris (PV) are examined.
Characterizing Distinct Subtypes of Autoimmune Blistering Skin Diseases
The clinical features and treatment responses of immunoglobulin A (IgA)-mediated epidermolysis bullosa acquisita(IgA-mediated EBA) and linear IgA bullous dermatosis (LABD) are characterized.
Bullous Pemphigoid Linked to Preexisting Stroke, Malignancies
A novel study asks: Does a correlation exist between preexisting comorbidities and serum titers of anti-BP180 and 230 antibodies in patients with bullous pemphigoid (BP)?
Inflammatory Bowel Disease and Inflammatory Dermatologic Condition Comorbidities: A Distinct Subgroup of IBD Patients
Researchers evaluated the prevalence and severity of dermatologic inflammatory conditions in patients with IBD.
Bullous Pemphigoid and Comorbid Psoriasis Associated With More Severe Erosion and Blisters
The prevalence of psoriasis in patients with bullous pemphigoid (BP) was estimated and the clinical and immunological features of patients with BP and psoriasis was clarified.
Reliable Cut-Off Values for BPDAI Score to Assess Severity of Bullous Pemphigoid Activity Established
Researchers sought to calculate BPDAI cut-off values defining mild, moderate, and severe bullous pemphigoid.
Pruritus Associated With Skin Conditions Increases Burden on Patients’ Quality of Life
The burden of pruritus in patients with chronic dermatoses was characterized in this investigation.
Bullous Pemphigoid Rises With Increasing Age, Incidence Highest in Elderly Men
The burden of bullous pemphigoid in the elderly population includes considerable risk for mortality; it should not be viewed as a rare disease in this patient group.
- Loading...
Loading...
Next post in General Dermatology
Loading... 
Loading...